Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 28, 2015 3:20 PM ET

Health Care Technology

Company Overview of IMS Health Holdings, Inc.

Company Overview

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, pr...

83 Wooster Heights Road

Danbury, CT 06810

United States

Founded in 1954

10,200 Employees

Phone:

203-448-4600

Key Executives for IMS Health Holdings, Inc.

Chairman, Chief Executive Officer and President
Age: 53
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice President
Age: 53
Total Annual Compensation: $457.5K
Senior Vice President of Global Technology & Operations
Age: 50
Total Annual Compensation: $405.9K
Senior Vice President of Global Services
Age: 49
Total Annual Compensation: $426.3K
Senior Vice President of Strategy & Global Product Management
Age: 49
Total Annual Compensation: $410.0K
Compensation as of Fiscal Year 2014.

IMS Health Holdings, Inc. Key Developments

IMS Health Holdings, Inc. Announces Executive Appointments, Effective April 1, 2015

IMS Health Holdings, Inc. appointed Kevin Knightly as Senior Vice President, Information Offerings, effective April 1, 2015. Mr. Knightly was previously Senior Vice President, Supplier Management. Robert Chu has been appointed Senior Vice President, Technology Solutions effective April 1, 2015. Mr. Chu is President, IMS Health Asia Pacific and previously was General Manager of IMS France. Earlier in his career, he spent 15 years at IBM Corporation in sales, consulting and technology leadership roles. Also effective April 1, Satwinder Sian, formerly Senior Vice President, Global Technology Operations, has been named strategic advisor to the Chief Executive Officer.

IMS Health Announces Pricing of €275 Million Senior Notes, Due April 1, 2023

IMS Health Holdings, Inc. announced the pricing of its offering of €275 million in gross proceeds of senior notes to be issued by IMS Health Incorporated. The net proceeds from the notes offering will be used to fund a portion of the purchase price for IMS Health’s previously announced proposed acquisition of certain customer relationship management and strategic data businesses of Cegedim, SA and for related fees and expenses. The notes will bear interest at a rate of 4.125% and will pay interest semi-annually in arrears on October 1 and April 1 of each year beginning on October 1, 2015. The notes will mature on April 1, 2023. The notes are being offered only to qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act of 1933 and outside the United States only to non-U.S. investors pursuant to Regulation S.

IMS Health Incorporated Intends to Raise €275 Million Through an Offering of Senior Notes Due 2023

IMS Health Holdings Inc. announced that its wholly-owned subsidiary, IMS Health Incorporated, intends to raise €275 million in gross proceeds through an offering of senior notes due 2023. The net proceeds from the notes offering will be used to fund a portion of the purchase price for IMS Health’s previously announced proposed acquisition of certain customer relationship management and strategic data businesses of Cegedim, SA and for related fees and expenses. The consummation of the notes offering is subject to market and other conditions. The notes are being offered only to qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act of 1933 and outside the United States only to non-U.S. investors pursuant to Regulation S.

Similar Private Companies By Industry

Company Name Region
Zipede Inc. United States
W3health Solutions, LLC United States
Vericom Corporation United States
Rx Vigil, Inc. United States
ELM Exchange, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 24, 2014
Cegedim SA, Information Solutions and Customer Relationship Management Business
Merger/Acquisition
May 8, 2014
Forcea NV/SA
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS Health Holdings, Inc., please visit www.imshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.